Biogen Inc (BIIB)
208.90
+6.44
(+3.18%)
USD |
NASDAQ |
Apr 26, 16:00
209.50
+0.60
(+0.29%)
After-Hours: 20:00
Biogen Debt to Equity Ratio: 0.4299 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.4299 |
December 31, 2023 | 0.4688 |
September 30, 2023 | 0.5031 |
June 30, 2023 | 0.4344 |
March 31, 2023 | 0.4554 |
December 31, 2022 | 0.4688 |
September 30, 2022 | 0.4915 |
June 30, 2022 | 0.6129 |
March 31, 2022 | 0.6471 |
December 31, 2021 | 0.6675 |
September 30, 2021 | 0.6971 |
June 30, 2021 | 0.6761 |
March 31, 2021 | 0.6803 |
December 31, 2020 | 0.694 |
September 30, 2020 | 0.6902 |
June 30, 2020 | 0.6565 |
March 31, 2020 | 0.4752 |
December 31, 2019 | 0.4463 |
September 30, 2019 | 0.4254 |
June 30, 2019 | 0.4592 |
March 31, 2019 | 0.4297 |
December 31, 2018 | 0.4553 |
September 30, 2018 | 0.4308 |
June 30, 2018 | 0.4835 |
March 31, 2018 | 0.4221 |
Date | Value |
---|---|
December 31, 2017 | 0.4708 |
September 30, 2017 | 0.5063 |
June 30, 2017 | 0.5623 |
March 31, 2017 | 0.5675 |
December 31, 2016 | 0.5368 |
September 30, 2016 | 0.5393 |
June 30, 2016 | 0.5738 |
March 31, 2016 | 0.6334 |
December 31, 2015 | 0.6963 |
September 30, 2015 | 0.618 |
June 30, 2015 | 0.0461 |
March 31, 2015 | 0.0501 |
December 31, 2014 | 0.054 |
September 30, 2014 | 0.0563 |
June 30, 2014 | 0.0617 |
March 31, 2014 | 0.0651 |
December 31, 2013 | 0.0691 |
September 30, 2013 | 0.0859 |
June 30, 2013 | 0.0923 |
March 31, 2013 | 0.1247 |
December 31, 2012 | 0.1639 |
September 30, 2012 | 0.1669 |
June 30, 2012 | 0.1746 |
March 31, 2012 | 0.1712 |
December 31, 2011 | 0.1656 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.4254
Minimum
Sep 2019
0.6971
Maximum
Sep 2021
0.554
Average
0.4973
Median
Debt to Equity Ratio Benchmarks
Eli Lilly and Co | 2.342 |
Bristol-Myers Squibb Co | 1.351 |
Gilead Sciences Inc | 1.094 |
AbbVie Inc | 5.732 |
Sage Therapeutics Inc | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 26.57B |
Total Liabilities (Quarterly) | 11.35B |
Shareholders Equity (Quarterly) | 15.21B |
Current Ratio | 2.096 |
Net Debt Paydown Yield | -0.17% |